Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Circulation
|
December 11, 1992
Intact and altered endothelium in regulation of vasomotion
A Lerman, J C Burnett
Circulation
|
October 1, 1985
Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure
T A Scriven, J C Burnett
Circulation
|
February 15, 1996
Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure
C R Cannan, J C Burnett, A Lerman
Circulation
|
November 1, 1986
The renal, forearm, and hormonal responses to standing in the presence and absence of propranolol
G L Bakris, D M Wilson, J C Burnett
Circulation
|
April 1, 1995
The role of neutral endopeptidase in dogs with evolving congestive heart failure
K B Margulies, P L Barclay, J C Burnett
Circulation
|
December 1, 1995
Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor
C R Cannan, J C Burnett, R R Brandt, et al.
Circulation
|
August 1, 1995
Elevation of circulating and ventricular adrenomedullin in human congestive heart failure
M Jougasaki, C M Wei, L J McKinley, et al.
Circulation
|
May 1, 1991
Endothelin has biological actions at pathophysiological concentrations
A Lerman, F L Hildebrand, L L Aarhus, et al.
Circulation
|
May 11, 1992
Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction
A Lerman, E K Sandok, F L Hildebrand, et al.
Circulation
|
June 1, 1993
Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction
M M Redfield, L L Aarhus, R S Wright, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Circulation
|
December 11, 1992
Intact and altered endothelium in regulation of vasomotion
A Lerman, J C Burnett
Circulation
|
October 1, 1985
Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure
T A Scriven, J C Burnett
Circulation
|
February 15, 1996
Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure
C R Cannan, J C Burnett, A Lerman
Circulation
|
November 1, 1986
The renal, forearm, and hormonal responses to standing in the presence and absence of propranolol
G L Bakris, D M Wilson, J C Burnett
Circulation
|
April 1, 1995
The role of neutral endopeptidase in dogs with evolving congestive heart failure
K B Margulies, P L Barclay, J C Burnett
Circulation
|
December 1, 1995
Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor
C R Cannan, J C Burnett, R R Brandt, et al.
Circulation
|
August 1, 1995
Elevation of circulating and ventricular adrenomedullin in human congestive heart failure
M Jougasaki, C M Wei, L J McKinley, et al.
Circulation
|
May 1, 1991
Endothelin has biological actions at pathophysiological concentrations
A Lerman, F L Hildebrand, L L Aarhus, et al.
Circulation
|
May 11, 1992
Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction
A Lerman, E K Sandok, F L Hildebrand, et al.
Circulation
|
June 1, 1993
Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction
M M Redfield, L L Aarhus, R S Wright, et al.
Page
of 3